Additionally, pancreatic cancer vaccines using radiation-treated pancreatic cancer cells and GM-CSF to stimulate systemic anti-tumor immunity are currently being tested in clinical trials (4, 5). The gene discussed is CSF2; the disease is familial pancreatic carcinoma.